OCT 14, 2021 8:30 AM PDT

Cancer-Sniffing Worms: The Future of Diagnostics?

WRITTEN BY: Tara Fernandez


Researchers have unlocked a way of sniffing out cancer in patients with very-early-stage pancreatic cancer. This time, instead of relying on dogs, the technology relies on the help of a much smaller animal: worms. 

Caenorhabditis elegans are transparent worms, about a millimeter long, that live in soil, particularly around rotting vegetation. A team of researchers from Osaka University looking for early detection methods for pancreatic cancer became interested in the potential of using C. elegans

Earlier studies revealed that the nematodes have a remarkable sense of smell. In addition, they breed quickly (they produce over 1000 eggs daily) and are easy to handle in assays such as N-NOSE, an established system for analyzing the movement of C. elegans in response to chemical signals. 

In the study, the cancer researchers performed a study in 83 patients with very-early-stage pancreatic cancer. They observed the movement patterns of the worms when they were exposed to urine samples from both the cancer patients and healthy controls. 

They found that the test had a sensitivity of 95.8 percent, even when the patients were in the very early stages of the disease. After undergoing surgery to remove the tumors, the patients tested negative on N-NOSE.

The researchers are confident that their cancer screening technology could soon become standard in diagnostic labs. “The clinical application C. elegans for the early diagnosis of cancer can certainly be expected in the near future,” wrote the authors. 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
OCT 05, 2021
Technology
Portable Sensor Could Help Diagnosis Heart Attacks Quickly
OCT 05, 2021
Portable Sensor Could Help Diagnosis Heart Attacks Quickly
According to the Centers for Disease Control, someone in the U.S. has a heart attack about every 40 seconds. Despite bei ...
NOV 11, 2021
Cancer
US Military Veterans: Cancer Risk and Cancer Research
NOV 11, 2021
US Military Veterans: Cancer Risk and Cancer Research
The US Department of Veteran’s Affairs (VA) estimates about 50,000 new cancer cases diagnosed each year. In total, ...
NOV 25, 2021
Cell & Molecular Biology
Analyzing Cells With Virtual Reality
NOV 25, 2021
Analyzing Cells With Virtual Reality
Research tools that are used to analyze gene expression have gotten cheaper, faster, and incredibly complex. An entire h ...
DEC 01, 2021
Cardiology
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
DEC 01, 2021
Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?
Congestive Heart Failure (CHF) is a serious medical condition that results in the heart not being able to pump to meet t ...
Loading Comments...